Skip to content
etfnews.live

Company

Nektar Therapeutics

United StatesWikipedia ↗

The ETFs we cover that hold this company, and its latest news.

Which ETFs hold Nektar Therapeutics?

Held by 39 covered funds. Sorted by Nektar Therapeutics’ share of each fund. Holdings as of each fund’s latest SEC filing.

FundShare of fund
LFSCF/m Emerald Life Sciences Innovation3.1%
PTHInvesco Dorsey Wright Healthcare Momentum2.6%
SPITF/m Emerald Special Situations2.1%
XPHState Street(R) SPDR(R) S&P(R) Pharmaceuticals1.9%
BBCVirtus LifeSci Biotech Clinical Trials0.8%
DWASInvesco Dorsey Wright SmallCap Momentum0.7%
IHEiShares U.S. Pharmaceuticals0.5%
HSPGXEmerald Growth Fund0.5%
PRFZInvesco Rafi US 1500 Small-Mid0.2%
POAGXPRIMECAP Odyssey Aggressive Growth Fund0.2%
IWOiShares Russell 2000 Growth0.1%
RUSCU.S. Small Cap Equity Active0.1%
RESMColumbia Research Enhanced Small Cap0.1%
TMFXMotley Fool Next Index0.1%
BBSCJPMorgan BetaBuilders U.S. Small Cap Equity0.1%
POGRXPRIMECAP Odyssey Growth Fund0.1%
RSSLGlobal X Russell 20000.1%
RFLRInnovator U.S. Small Cap Managed Floor0.1%
IWMiShares Russell 20000.1%
NSIDXSmall Cap Index Fund0.1%
ISCViShares Morningstar Small-Cap Value0.1%
SCHASchwab U.S. Small-Cap0.1%
ISCBiShares Morningstar Small-Cap0.0%
FHLCFidelity MSCI Health Care Index0.0%
VHTVanguard Health Care Index Fund0.0%
VXFVanguard Extended Market Index Fund0.0%
SSMHXState Street Small/mid Cap Equity Index Portfolio0.0%
WSMLiShares MSCI World Small-Cap0.0%
IWNiShares Russell 2000 Value0.0%
ONEQFidelity Nasdaq Composite Index0.0%
KCXSXKnights of Columbus U.S. ALL CAP INDEX FUND0.0%
ITOTiShares Core S&P Total U.S. Stock Market0.0%
SCHBSchwab U.S. Broad Market0.0%
VITPXVanguard Institutional Total Stock Market Index Fund0.0%
VTIVanguard Total Stock Market Index Fund0.0%
IWViShares Russell 30000.0%
TILTFlexShares Morningstar US Market Factor Tilt Index Fund0.0%
SSBIXState Street Balanced Index Fund0.0%
AVTMAvantis Total Equity Markets0.0%

Where to buy these ETFs

[Affiliate and risk wording from the law firm]

Latest Nektar Therapeutics news

No recent stories about Nektar Therapeutics.